<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153344</url>
  </required_header>
  <id_info>
    <org_study_id>APHP190937</org_study_id>
    <secondary_id>2019-A02526-51</secondary_id>
    <nct_id>NCT04153344</nct_id>
  </id_info>
  <brief_title>Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis</brief_title>
  <acronym>NEF-1</acronym>
  <official_title>Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to study the function of the pigment epithelium in patients&#xD;
      with neurofibromatosis type 1 using electro-oculogram to confirm abnormally high values&#xD;
      reported in previous studies, but also to correlate this hyperactivity of the pigment&#xD;
      epithelium with the presence and size of choroidal hyperreflective areas observed in&#xD;
      infra-red imaging of the fundus.&#xD;
&#xD;
      The hypothesis of the study is that the function of the pigment epithelium measured by the&#xD;
      electro-oculogram correlates with the surface of choroidal hyperreflective areas. Finally,&#xD;
      the potential consequences of a supra-normal function of the pigment epithelium on the global&#xD;
      retinal function are not known. A full-field electroretinogram will evaluate the global&#xD;
      neurosensory retinal function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with neurofibromatosis type 1 have numerous eye problems: glioma of the optic&#xD;
      pathways, Lisch nodules, palpebral involvement by plexiform neurofibromas, orbital dysplasia,&#xD;
      etc. With the emergence of multimodal imaging in ophthalmology a new ocular involvement has&#xD;
      been described: choroidal hyperreflective areas. They are located in the most superficial&#xD;
      layers of the choroid, adjacent to the retinal pigment epithelium, visible only on infra-red&#xD;
      imaging of the fundus. These areas are frequently observed, about 90% in adults and 70 to 80%&#xD;
      in children. With a sensitivity of 0.83 and a specificity of 0.96, these lesions would have&#xD;
      their place as a diagnostic criterion for neurofibromatosis type 1.&#xD;
&#xD;
      In parallel, two successive studies have evaluated the function of the retinal pigment&#xD;
      epithelium using electro-oculograms; they showed in patients with neurofibromatosis type 1 a&#xD;
      significant increase in the Arden ratio, reflecting hyperactivity of the pigment epithelium.&#xD;
&#xD;
      The objective of this study is to study the function of the pigment epithelium in patients&#xD;
      with neurofibromatosis type 1, using electro-oculogram to confirm these abnormally high&#xD;
      values, but also to correlate this hyperactivity of the pigment epithelium to the presence&#xD;
      and total area of choroidal lesions observed in infra-red imaging of the fundus.&#xD;
&#xD;
      The hypothesis of the study is that the function of the pigment epithelium measured by the&#xD;
      electro-oculogram correlates with the surface of the choroidal hyperreflective areas.&#xD;
      Finally, the potential consequences of a supra-normal function of the pigment epithelium on&#xD;
      the global retinal function are not known. A full-field electroretinogram will evaluate the&#xD;
      global neurosensory retinal function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 11, 2020</start_date>
  <completion_date type="Actual">July 21, 2020</completion_date>
  <primary_completion_date type="Actual">July 21, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dark trough value</measure>
    <time_frame>12 months</time_frame>
    <description>Electro-oculogram : dark trough value (μV).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Light/dark (Arden) ratio</measure>
    <time_frame>12 months</time_frame>
    <description>Electro-oculogram : ratio between the light and dark potentials.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and area of infrared hyperreflective areas</measure>
    <time_frame>12 months</time_frame>
    <description>Infrared fundus picture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Values of the amplitudes</measure>
    <time_frame>12 months</time_frame>
    <description>Electroretinogram : values of the amplitudes (μV) of a- and/or b-waves for dark-adapted 0.01, dark adapted 3.0, dark-adapted 10.0, dark-adapted 3.0 oscillatory potentials, light-adapted 3.0, and light-adapted 3.0 flicker.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Values of the peak times</measure>
    <time_frame>12 months</time_frame>
    <description>Electroretinogram : values of the peak times (ms) of a- and/or b-waves for dark-adapted 0.01, dark adapted 3.0, dark-adapted 10.0, dark-adapted 3.0 oscillatory potentials, light-adapted 3.0, and value of the peak-to-peak time (ms) for light-adapted 3.0 flicker.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Neurofibromatosis Type 1</condition>
  <arm_group>
    <arm_group_label>Infrared hyperreflective area</arm_group_label>
    <description>Patients with neurofibromatosis type 1 and with infrared hyperreflective areas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No infrared hyperreflective areas</arm_group_label>
    <description>Patients with neurofibromatosis type 1 and with no infrared hyperreflective areas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Patients with no neurofibromatosis type 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electro-oculogram</intervention_name>
    <description>Electrophysiological recording of changes in electrical potential across the retinal pigmentary epithelium during successive periods of dark and light adaptation, according to ISCEV standards. Results will comprise dark trough value and light/dark (Arden) ratio.</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Infrared hyperreflective area</arm_group_label>
    <arm_group_label>No infrared hyperreflective areas</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Full-field electroretinogram</intervention_name>
    <description>Electrophysiological recording of retinal function. Results will comprise amplitudes and latencies of each electroretinography response (dark-adapted 0.01, dark-adapted 3.0, dark-adapted 10.0, dark-adapted 3.0 oscillatory potentials, light-adapted 3.0, light-adapted 3.0 flicker).</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Infrared hyperreflective area</arm_group_label>
    <arm_group_label>No infrared hyperreflective areas</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients consulting the ophthalmology department of Necker-Enfants Malades Hospital:&#xD;
&#xD;
          -  10 patients with neurofibromatosis type 1 without infrared hyperreflective areas&#xD;
&#xD;
          -  10 patients with neurofibromatosis type 1 and infrared hyperreflective areas&#xD;
&#xD;
          -  10 control patients with no retinal disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with neurofibromatosis type 1, aged 7 years or older:&#xD;
&#xD;
               -  Presence of hyper-reflective choroidal lesions in infra-red imaging in the group&#xD;
                  with choroidal lesions.&#xD;
&#xD;
               -  Absence of hyper-reflective choroidal lesions in infra-red imaging in the group&#xD;
                  without choroidal lesions.&#xD;
&#xD;
          -  Control patients free from retinal or choroidal pathology, matched for age to patients&#xD;
             in the group with neurofibromatosis type 1.&#xD;
&#xD;
          -  Patients consulting the ophthalmology department of Necker-Enfants Malades Hospital.&#xD;
&#xD;
          -  Non-opposition of the holders of the parental authority and the minor patient;&#xD;
             non-opposition of the major patient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Impossibility to perform an electro-oculogram, especially because of an oculomotor&#xD;
             disorder, or an electroretinogram, for example because of hyperactivity.&#xD;
&#xD;
          -  Significant impairment of visual function.&#xD;
&#xD;
          -  Retinal pathology proved.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthieu Robert, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Brémond-Gignac, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Lubiński W, Zajaczek S, Sych Z, Penkala K, Palacz O, Lubiński J. Electro-oculogram in patients with neurofibromatosis type 1. Doc Ophthalmol. 2001 Sep;103(2):91-103.</citation>
    <PMID>11720259</PMID>
  </reference>
  <reference>
    <citation>Viola F, Villani E, Natacci F, Selicorni A, Melloni G, Vezzola D, Barteselli G, Mapelli C, Pirondini C, Ratiglia R. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology. 2012 Feb;119(2):369-75. doi: 10.1016/j.ophtha.2011.07.046. Epub 2011 Oct 2.</citation>
    <PMID>21963267</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>November 4, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurofibromatosis type 1</keyword>
  <keyword>Infrared hyperreflective areas</keyword>
  <keyword>Hyperactivity of the pigment epithelium</keyword>
  <keyword>Electro-oculogram</keyword>
  <keyword>Electroretinogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurofibromatoses</mesh_term>
    <mesh_term>Neurofibromatosis 1</mesh_term>
    <mesh_term>Neurofibroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

